Novo Nordisk A/S Stock Hits New 52-Week High (NVO)
Novo Nordisk A/S (NYSE:NVO) hit a new 52-week high Thursday as it is currently trading at $160.25, above its previous 52-week high of $160.20 with 112,631 shares traded as of 10:54 a.m. ET. Average volume has been 323,000 shares over the past 30 days.
Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model NEW YORK ( TheStreet) -- Novo Nordisk A/S (NYSE: NVO) hit a new 52-week high Thursday as it is currently trading at $160.25, above its previous 52-week high of $160.20 with 112,631 shares traded as of 10:54 a.m. ET. Average volume has been 323,000 shares over the past 30 days. Novo Nordisk A/S has a market cap of $91.1 billion and is part of the health care sector and drugs industry. Shares are up 36.3% year to date as of the close of trading on Wednesday. Novo Nordisk A/S, a healthcare company, engages in the discovery, development, manufacture, and marketing of pharmaceutical products in Denmark and internationally. The company operates in two segments, Diabetes Care and Biopharmaceuticals. The company has a P/E ratio of four, below the average drugs industry P/E ratio of 27.1 and below the S&P 500 P/E ratio of 17.7.
TheStreet Ratings rates Novo Nordisk A/S as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, increase in net income, notable return on equity, expanding profit margins and good cash flow from operations. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. You can view the full Novo Nordisk A/S Ratings Report. See all 52-week high stocks or get investment ideas from our investment research center. FREE from Real Money's Jim Cramer: Winners and Losers Election 2012 - Steps to take NOW so you can profit no matter who is in charge! Free download now.